PGP and breast carcinoma: It is possible that Pgp plays a dominant role for chemoresistance to eribulin in breast cancer but not in leiomyosarcoma or there were errors in posttranscriptional processing of Pgp in the eribulin-resistant cell line, and the exact mechanism should be studied further.